# Analyzing IBS to Identify Biomarkers and Microbiome Signatures

> **NCT02419963** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 26 (actual)

## Conditions studied

- Diarrhoea Predominant Irritable Bowel Syndrome
- IBS

## Interventions

- **PROCEDURE:** endoscopy for tissue biopsy
- **OTHER:** Blood Sample
- **OTHER:** Stool Sample

## Key facts

- **NCT ID:** NCT02419963
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-12-12
- **Final completion:** 2016-12-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02419963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02419963, "Analyzing IBS to Identify Biomarkers and Microbiome Signatures". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02419963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*